
Sitagliptin (50mg) + Metformin (500mg)
Rayax Drug India
Sitagliptin 50mgPack Size
Strip of 15 tablets
Price
Save ₹7
that's 4% off!
Active composition
+1 more active ingredient
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Emsita-M 50/500 Tablet contains Sitagliptin and Metformin, a combination medication used to help manage blood glucose levels. Sitagliptin works by increasing the activity of incretin hormones that stimulate insulin release and reduce glucose production in the liver after meals. Metformin works by lowering glucose production in the liver and improving insulin sensitivity in the body. Together these medicines help maintain stable blood sugar levels and improve glycemic control. Proper blood glucose management is important for preventing long term complications associated with diabetes and maintaining metabolic health. The medicine is usually taken according to the dosage recommended by a healthcare professional who may monitor blood sugar levels during treatment. Maintaining healthy lifestyle habits such as balanced diet and regular exercise can further improve treatment effectiveness. When used properly, Emsita-M 50/500 Tablet helps support effective diabetes management.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Emsita-M 50/500 Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Emsita-M 50/500 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Emsita-M 50/500 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Emsita-M 50/500 Tablet may be needed. Please consult your doctor. Use of Emsita-M 50/500 Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Emsita-M 50/500 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Emsita-M 50/500 Tablet

Sitagliptin (50mg) + Metformin (500mg)
Rayax Drug India
Sitagliptin 50mgPack Size
Strip of 15 tablets
Price
Save ₹7
that's 4% off!
Active composition
+1 more active ingredient
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Emsita-M 50/500 Tablet contains Sitagliptin and Metformin, a combination medication used to help manage blood glucose levels. Sitagliptin works by increasing the activity of incretin hormones that stimulate insulin release and reduce glucose production in the liver after meals. Metformin works by lowering glucose production in the liver and improving insulin sensitivity in the body. Together these medicines help maintain stable blood sugar levels and improve glycemic control. Proper blood glucose management is important for preventing long term complications associated with diabetes and maintaining metabolic health. The medicine is usually taken according to the dosage recommended by a healthcare professional who may monitor blood sugar levels during treatment. Maintaining healthy lifestyle habits such as balanced diet and regular exercise can further improve treatment effectiveness. When used properly, Emsita-M 50/500 Tablet helps support effective diabetes management.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Emsita-M 50/500 Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Emsita-M 50/500 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Emsita-M 50/500 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Emsita-M 50/500 Tablet may be needed. Please consult your doctor. Use of Emsita-M 50/500 Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Emsita-M 50/500 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Emsita-M 50/500 Tablet













